GSK Buys Out Novartis Stake In Healthcare JV For $13B
GlaxoSmithKline PLC has agreed to a buyout of Novartis' stake in their consumer health care joint venture for $13 billion and will consider a strategic review of nutrition products to finance...To view the full article, register now.
Already a subscriber? Click here to view full article